Cargando…
Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients
INTRODCUTION: Through interaction with receptors TNFR1 and TNFR2, TNF-α activates a signal path, which exacerbates an inflammatory process, constituting an inseparable element of psoriasis. AIM: To evaluate changes in the expression of TNF-α, TNFR1, TNFR2 during the 4-year-long adalimumab therapy in...
Autores principales: | Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Kruszniewska-Rajs, Celina, Swinarew, Andrzej, Jasik, Krzysztof, Rozwadowska, Beata, Krawczyk, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675078/ https://www.ncbi.nlm.nih.gov/pubmed/33240014 http://dx.doi.org/10.5114/ada.2020.100484 |
Ejemplares similares
-
Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020) -
The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis – preliminary report
por: Krawczyk, Agata, et al.
Publicado: (2021) -
Differences in expression of genes related to drug resistance and miRNAs regulating their expression in skin fibroblasts exposed to adalimumab and cyclosporine A
por: Grabarek, Beniamin, et al.
Publicado: (2020) -
Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2018) -
Expression of genes related to inflammation – IL-6, IL-8, and IFN-γ in monitoring ustekinumab therapy: preliminary results
por: Kruszniewska-Rajs, Celina, et al.
Publicado: (2022)